Summary of Changes to Areas of Science
Effective January 2020
New Level 1 and Level 2 Areas of Science descriptors
| Areas of Science – Level 1 | Areas of Science – Level 2 |
|---|---|
| Artificial Intelligence | Artificial Intelligence |
| Machine Learning |
Effective January 2018
New Level 1 Areas of Science descriptors
| Updated January 2018 Areas of Science - Level 1 |
|---|
| Commercialization |
Updated Level 1 Areas of Science descriptors
| Original Areas of Science – Level 1 |
Updated May 2017 Areas of Science – Level 1 |
|---|---|
| Mental Health | Mental Health and Behavioural Conditions |
| Pharmacology | Pharmacological, Toxicological and Pharmaceutical Sciences |
New Level 2 Areas of Science descriptors
| Original Areas of Science – Level 1 |
Updated January 2018 Areas of Science – Level 2 |
|---|---|
| Cancer | Pediatrics |
| Cardiovascular, Respiratory and Circulatory Systems |
Cerebrovascular Sciences (including stroke) |
| Commercialization | Industry Research & Development |
| Commercialization | Intellectual Property |
| Commercialization | Technology Transfer |
| Commercialization | Venture Capital & Financing |
| Health Determinants | Epidemiology |
| Health Services and Systems | Emergency Care and Critical Care |
| Immunology and Infection | Infectious Diseases |
| Indigenous Health | Indigenous Knowledge |
| Methods Development and Modelling | Biostatistics |
| Musculoskeletal Health | Rehabilitation and Physical Therapy |
| Neurosciences | Motor Systems |
| Neurosciences | Neural Circuits and Systems |
| Neurosciences | Neural Excitability and Synapse |
| Neurosciences | Neurodegeneration |
| Neurosciences | Neurodevelopment |
| Neurosciences | Neuroinflammation |
| Neurosciences | Neurological disorders |
| Pharmacological, Toxicological and Pharmaceutical Sciences | Translational and clinical pharmacology |
| Population and Health | Nutritional Health Sciences |
Updated Level 2 Areas of Science descriptors
| Areas of Science – Level 1 |
Original Areas of Science – Level 2 |
Updated May 2017 Areas of Science – Level 2 |
|---|---|---|
| Digestive, Endocrine and Excretory Systems | Metabolism and Disease (including Metabolomics) | Metabolism and Disease (including Obesity, Diabetes and Metabolomics) |
| Genetics | Molecular and Functional Genetics | Molecular and Functional Genetics and Epigenetics |
| Health Services and Systems | Healthcare Systems & Research | Healthcare Systems & Health Economics Research |
| Immunology and Infection | Antimicrobial Drug Resistance, Drug Discovery and Therapeutics | Antimicrobial Drug Resistance, Drug Discovery and Therapeutics (including vaccines) |
| Immunology and Infection | Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics | Antiviral Drug Resistance, Viral Vaccine Development and Therapeutics (including vaccines) |
| Immunology and Infection | Immunology | Immunology and Autoimmune Diseases (including rheumatology) |
| Mental Health and Behavioural Conditions (formerly "Mental Health") | Neuropsychiatry and Neuropsychology | Psychology and Psychiatry |
| Neurosciences | Cognition and Communication Sciences | Cognition, Communication and Behaviour (including sleep and memory) |
| Neurosciences | Sensory and Motor Neurosciences | Sensory Systems (including visual, auditory and pain) |
| Pharmacological, Toxicological and Pharmaceutical Sciences (formerly “Pharmacology”) | Drug Action, and Metabolism | Drug Action, Toxicology and Metabolism |
| Population and Health | Legal, Social and Ethical Issues in Health, Health Systems and Health Research | Ethical, Legal, and Social Issues in Health, Health Systems and Health Research |
| Reproduction and Development | Clinical Embryology and Pediatrics | Clinical Embryology, Neonatalogy, and Pediatrics |
- Date modified: